DelveInsight has launched a new report on Lupus Nephritis Market Insights, Epidemiology and Market Forecast-2030
DelveInsight's "Lupus Nephritis - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Lupus Nephritis, historical and forecasted epidemiology as well as the Lupus Nephritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Lupus Nephritis market report provides current treatment practices, emerging drugs, Lupus Nephritis market share of the individual therapies, current and forecasted Lupus Nephritis market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Lupus Nephritis treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Lupus nephritis (LN) is a common and potentially devastating manifestation of SLE. It is a leading cause of morbidity and mortality in patients with SLE. LN leads to inflammation of small blood vessels which play an important role in filtering waste materials in the kidney. It also involves the inflammation of glomeruli.
Systemic lupus erythematosus(SLE) is a prototypic autoimmune disease and is the most common form of lupus that can affect multiple tissues and organs. The disease is being characterized by the production of antibodies to components of the cell nucleus in association with a diverse array of clinical manifestations. The primary pathological findings in patients with SLE include inflammation, vasculitis, immune complex deposition, and vasculopathy.
Request for :- Lupus Nehritis free sample page
Epidemiology
The Lupus Nephritis epidemiology division provide insights about historical and current Lupus Nephritis patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Report Key facts:-
1. As per DelveInsight’s estimates, total Prevalent population of Lupus Nephritis in the 7 major markets was190,819 in 2017
2. According toDelveInsight’s analysis, the United Sates accounted for the maximum number of LN patients with 134,190cases in 2017 followed by Italy with 17,013cases
3. DelveInsight estimates,in 2017, Proteinuria associated with LN cases were found in all of the diagnosed cases, while second common manifestation in LN was microscopic hematuria with 85,882 cases(80%).
"A socioeconomic gradient is apparent in the prevalence of LN, with increased prevalence in poorer geographic areas that persists after adjustment for age, sex, and ethnicity. The reasons for this are unclear, but recent studies have shed some light on the same. In many poor US urban areas, LN patients are more likely to be underinsured and to utilize emergency room care at higher rates than those in more affluent areas, possibly leading to suboptimal care"
Major key companies are working on Lupus Nehritis are given below:-
1. GlaxoSmithKline Pharma Co.
2. Aurinia Pharmaceutical Co.
Drugs covered which are given below:-
1. Belimumab
2. Voclosporin
Table of contents
1. Key Insights
2. Executive Summary of Lupus Nephritis
3. Competitive Intelligence Analysis for Lupus Nephritis
4. Lupus Nephritis: Market Overview at a Glance
4.1. Lupus Nephritis Total Market Share (%) Distribution in 2017
4.2. Lupus Nephritis Total Market Share (%) Distribution in 2030
5. Lupus Nephritis: Disease Background and Overview
6. Patient Journey
7. Lupus Nephritis Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
8.1. Lupus Nephritis Treatment and Management
8.2. Lupus Nephritis Treatment Algorithm
9. Unmet Needs
10. Key Endpoints of Lupus Nephritis Treatment
11. Marketed Products
12. Emerging Therapies
13. Lupus Nephritis: Seven Major Market Analysis
13.1. Key Findings
13.2. Lupus Nephritis Market Size in 7MM
13.3. Lupus Nephritis Market Size by Therapies in the 7MM
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Lupus Nephritis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
20.1. Bibliography
20.2. Report Methodology
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Why should you buy this report?
- The report will help in developing business strategies by understanding trends shaping and driving the Lupus Nephritis market
- To understand the future market competition in the Lupus Nephritis market and Insightful review of the key market drivers and barriers
- Organize sales and marketing efforts by identifying the best opportunities for Lupus Nephritis in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
- Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
- Organize sales and marketing efforts by identifying the best opportunities for Lupus Nephritis market
- To understand the future market competition in the Lupus Nephritis market
Related Report:-
1. Lupus Nephritis - Pipeline Insights, 2020
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
